Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-12-19

FDA Approved: SINUS AND COLD D — Supplemental Application (Meijer Distribution Inc)

View source ↗

Summary

FDA approves a supplemental ANDA for Sinus and Cold D, a combination product containing naproxen sodium and pseudoephedrine hydrochloride distributed by Meijer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SINUS AND COLD D (Naproxen Sodium and Pseudoephedrine Hydrochloride)

Snippet

SUPPL AP for SINUS AND COLD D (NAPROXEN SODIUM, PSEUDOEPHEDRINE HCL)